[HTML][HTML] Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review

KL Mooney, LW Bassett, SK Apple - Modern Pathology, 2016 - Elsevier
Optimal management of high-risk breast lesions detected by mammogram yielding atypical
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in …

Multidisciplinary considerations in the management of high-risk breast lesions

S Krishnamurthy, T Bevers, H Kuerer… - American Journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this review is to discuss the controversy and lack of consensus
in the management of high-risk breast lesions, including flat epithelial atypia, atypical ductal …

Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision

MP Murray, C Luedtke, L Liberman, T Nehhozina… - Cancer, 2013 - Wiley Online Library
BACKGROUND: No consensus exists on the need to excise breast lesions that yield classic
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …

Variability in the management recommendations given for high-risk breast lesions detected on image-guided core needle biopsy at US academic institutions

E Falomo, C Adejumo, KA Carson, S Harvey… - Current Problems in …, 2019 - Elsevier
The purpose of this study was to describe and compare the management recommendations
provided in the setting of a high-risk lesion diagnosed on core needle biopsy of the breast at …

Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?

B Niell, M Specht, B Gerade… - American Journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The management of lobular neoplasia (LN) on percutaneous core breast
biopsies remains controversial. Published upgrade rates after surgical excision vary widely …

Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution

X Li, Z Ma, TM Styblo, CA Arciero, H Wang… - Breast cancer research …, 2021 - Springer
Background The management of high-risk breast lesions diagnosed on image-guided core
biopsy remains controversial. We implemented a high-risk breast conference attended by …

Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core‐needle biopsy

AR Donaldson, C McCarthy, S Goraya, HJ Pederson… - Cancer, 2018 - Wiley Online Library
BACKGROUND Breast cancer risk estimates for atypical lesions are based primarily on case‐
control studies of patients with open biopsies. The authors report the cumulative breast …

Core breast biopsies showing lobular carcinoma in situ should be excised and surveillance is reasonable for atypical lobular hyperplasia

LQC Sen, WA Berg, RJ Hooley… - American Journal of …, 2016 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy: correlation with excision specimen

IT Yeh, D Dimitrov, P Otto, AR Miller… - … of pathology & …, 2003 - meridian.allenpress.com
Context.—Management of breast needle core biopsies diagnosed as atypical ductal
hyperplasia, atypical lobular hyperplasia, and lobular carcinoma in situ is controversial …

[HTML][HTML] Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy

S Chaudhary, L Lawrence, G McGinty, K Kostroff… - Modern Pathology, 2013 - Elsevier
There are no consensus guidelines for the management of lobular neoplasia diagnosed on
core biopsy as the highest risk factor for cancer. This study aimed to assess the risk of …